Winning for
whistleblowers since 1984

Kohn, Kohn & Colapinto is the top whistleblower law firm.

hm-icn-1

Qui Tam
Whistleblowers

hm-icn-2

Tax Fraud
Whistleblowers

hm-icn-3

Mortgage &
Banking Fraud

hm-icn-4

False
Claims Act

hm-icn-5

SEC
Whistleblowers

hm-icn-6

Foreign Corrupt
Practices

can-you-blow-the-whistle-on-the-president

TOP
50 ELITE

One of The Leading Plaintiffs Firms In America As Chosen By The Editors of The National Law Journal.

OUR FIRM

Founded in 1988, Kohn, Kohn & Colapinto has won numerous landmark decisions, rewriting workplace law while earning hundreds of millions of dollars in damages for our clients, protecting the public, and saving the taxpayers billions of dollars.

REQUEST

A FREE
CONSULTATION

CONTACT US

A Law Firm Dedicated to Protecting Whistleblowers

KKC's experienced attorneys allow whistleblowers like you to confidentially and anonymously report fraud and waste to proper authorities. With over 30+ years working exclusively with whistleblowers in the United States and abroad, we know what it takes to safeguard whistleblowers and seek rewards for their courageous effort. We helped write whistleblower laws and have worked tirelessly to establish whistleblower reward laws. Courageous whistleblowers represented by KKC have enabled us to protect the environment, free the innocent, and ultimately allow us to recover billions of dollars stolen from taxpayers and innocent investors.

kkc_home_blog_img_1

Winning The Largest Individual Whistleblower Reward in History

Represented Bradley Birkenfeld who made history when he obtained a $104,000,000 whistleblower reward. It was the largest individual whistleblower reward in the twenty-five year history of federal qui tam or whistleblower reward laws, for reporting IRS Tax Fraud.

kkc_home_blog_img_2

Holding big banks accountable

Represent Whistleblowers in largest money laundering scandal in history.

kkc_home_blog_img_3

Holding big Pharma accountable for ripping off medicare

In Richardson v. Bristol Myers Squibb, won one of the largest pharmaceutical False Claims qui tam cases in U.S. history, resulting in civil payments..

KKC IN THE NEWS

Highlighting important news, legal developments and policy issues critical
to whistleblowers and their advocates.

latest news

whistleblower blog

Yesterday, leading whistleblower attorney and partner at Kohn, Kohn & Colapinto David Colapinto took an important look at the protections federal whistleblowers […]

Three whistleblowers who filed qui tam lawsuits against Avanir Pharmaceuticals (Avanir) will split a whistleblower reward of over $23 million. […]

The Securities and Exchange Commission’s (SEC or Commission) proposed amendments to the SEC whistleblower program will undermine the program, according to the […]

FAQ

The strongest whistleblower protection law is the False Claims Act also known as the "Lincoln Law" or "qui tam." For more than 150 years this law was used to combat fraud and waste in government programs, health care fraud, and a slew of pharmaceutical settlements. Read the most frequently asked questions by visiting the False Claims Act FAQ page.

The Dodd-Frank Act SEC Whistleblower Program is a major piece of reform legislation covering commodities and securities actions worldwide. The Act is meant primarily to promote financial stability by improving accountability and transparency in the financial system and minimize harm to investors. Read the most frequently asked questions by visiting the SEC Whistleblower Program FAQ page

The Internal Revenue Act permits individuals who provide original information to the Internal Revenue Service (“IRS”) about a violation of the tax laws or the underpayment of taxes to obtain monetary reward if their information results in a sanction against the tax law violator. Read the most frequently asked questions by visiting the IRS Whistleblower program FAQ page.

The Foreign Corrupt Practices Act (FCPA) targets bribery of foreign government officials by publicly traded corporations or U.S. persons. It is the most powerful and effective transnational anti-corruption law in the world. Read the most frequently asked questions by visiting the Foreign Corrupt Practices FAQ page

In 2002, Congress passed the historic Sarbanes-Oxley Act, which protects employees of publicly traded companies who report violations of Securities and Exchange Commission regulations or any provision of federal law relating to fraud against the shareholders. Read the most frequently asked questions by visiting the Sarbanes-Oxley Act FAQ page.

How to be
A Whistleblower